WAVE Life Sciences Ltd.
WVE
$5.92
$0.081.37%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 108.30M | 53.61M | 110.50M | 112.91M | 113.31M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 108.30M | 53.61M | 110.50M | 112.91M | 113.31M |
| Cost of Revenue | 159.68M | 149.11M | 139.56M | 132.48M | 130.01M |
| Gross Profit | -51.38M | -95.50M | -29.06M | -19.56M | -16.70M |
| SG&A Expenses | 59.02M | 56.55M | 54.64M | 52.61M | 51.29M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 218.71M | 205.66M | 194.19M | 185.08M | 181.30M |
| Operating Income | -110.40M | -152.05M | -83.69M | -72.17M | -68.00M |
| Income Before Tax | -97.01M | -142.52M | -74.16M | -62.34M | -58.19M |
| Income Tax Expenses | -- | 0.00 | -677.00K | -677.00K | -677.00K |
| Earnings from Continuing Operations | -97.01 | -142.52 | -73.49 | -61.67 | -57.51 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -97.01M | -142.52M | -73.49M | -61.67M | -57.51M |
| EBIT | -110.40M | -152.05M | -83.69M | -72.17M | -68.00M |
| EBITDA | -106.51M | -147.98M | -79.37M | -67.56M | -63.00M |
| EPS Basic | -0.78 | -1.11 | -0.58 | -0.53 | -0.55 |
| Normalized Basic EPS | -0.49 | -0.70 | -0.37 | -0.33 | -0.35 |
| EPS Diluted | -0.80 | -1.12 | -0.59 | -0.53 | -0.56 |
| Normalized Diluted EPS | -0.50 | -0.70 | -0.37 | -0.33 | -0.35 |
| Average Basic Shares Outstanding | 552.85M | 500.99M | 474.45M | 450.39M | 423.17M |
| Average Diluted Shares Outstanding | 563.65M | 500.99M | 475.40M | 451.34M | 424.12M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |